12 results on '"Agréus, Lars"'
Search Results
2. Effect of on-demand vs continuous prescription of proton pump inhibitors on symptom burden and quality of life: results of a real-world randomized controlled trial in primary care patients with gastroesophageal reflux disease.
- Author
-
Andreasson A, Agréus L, Mastellos N, Bliźniuk G, Waśko-Czopnik D, Angelaki A, Theodosaki E, Lionis C, Hek K, Verheij R, Wright E, Durbaba S, Muris J, Bródka P, Saganowski S, Ethiér JF, Curcin V, and Delaney B
- Subjects
- Humans, Female, Male, Middle Aged, Adult, Patient Reported Outcome Measures, Aged, Europe, Treatment Outcome, Symptom Burden, Proton Pump Inhibitors administration & dosage, Proton Pump Inhibitors therapeutic use, Gastroesophageal Reflux drug therapy, Quality of Life, Primary Health Care
- Abstract
Objectives: This study aimed to assess the impact of on-demand versus continuous prescribing of proton pump inhibitors (PPIs) on symptom burden and health-related quality of life in patients with gastroesophageal reflux disease (GERD) presenting to primary care., Methods: Thirty-six primary care centres across Europe enrolled adult GERD patients from electronic health records. Participants were randomised to on-demand or continuous PPI prescriptions and were followed for 8 weeks. PPI intake, symptom burden, and quality of life were compared between the two groups using mixed-effect regression analyses. Spearman's correlation was used to assess the association between changes in PPI dose and patient-reported outcomes., Results: A total of 488 patients (median age 51 years, 58% women) completed the initial visit, with 360 attending the follow-up visit. There was no significant difference in PPI use between the continuous and on-demand prescription groups ( b =.57, 95%CI:0.40-1.53), although PPI use increased in both groups ( b = 1.33, 95%CI:0.65 - 2.01). Advice on prescribing strategy did not significantly affect patient-reported outcomes. Both symptom burden (Reflux Disease Questionnaire, b=-0.61, 95%CI:-0.73 - -0.49) and quality of life (12-item Short Form Survey physical score b = 3.31, 95%CI:2.17 - 4.45) improved from baseline to follow-up in both groups. Increased PPI intake correlated with reduced reflux symptoms ( n = 347, ρ=-0.12, p = 0.02) and improved quality of life ( n = 217, ρ = 0.16, p = 0.02)., Conclusion: In real-world settings, both continuous and on-demand PPI prescriptions resulted in similar increases in PPI consumption with no difference in treatment effects. Achieving an adequate PPI dose to alleviate reflux symptom burden improves quality of life in GERD patients. EudraCT number 2014-001314-25.
- Published
- 2024
- Full Text
- View/download PDF
3. Colonoscopy findings in high-risk individuals compared to an average-risk control population.
- Author
-
Forsberg A, Kjellström L, Andreasson A, Jaramillo E, Rubio CA, Björck E, Agréus L, Talley NJ, and Lindblom A
- Subjects
- Adenoma pathology, Adolescent, Adult, Age Factors, Aged, Aged, 80 and over, Case-Control Studies, Colorectal Neoplasms pathology, Colorectal Neoplasms, Hereditary Nonpolyposis pathology, Female, Humans, Kaplan-Meier Estimate, Logistic Models, Male, Mass Screening, Middle Aged, Risk Factors, Sex Factors, Sweden, Young Adult, Adenoma diagnosis, Colonoscopy methods, Colorectal Neoplasms diagnosis, Colorectal Neoplasms epidemiology, Colorectal Neoplasms, Hereditary Nonpolyposis diagnosis, Polyps pathology
- Abstract
Background and Aims: There is clear evidence of reduced morbidity and mortality from regular colonoscopy programs in patients with Lynch syndrome (LS). Today, also individuals with empirically increased risks of colorectal cancer (CRC) are offered colonoscopic surveillance. The aim was to compare the findings at the first screening colonoscopy in LS carriers, and individuals with an increased risk of bowel cancer due to family history of CRC with a control population., Methods: Altogether 1397 individuals with an increased risk for CRC were divided in four risk groups: one with LS carriers and three groups with individuals with different family history of CRC. The findings were compared between the different risk groups and a control group consisting of 745 individuals from a control population who took part in a population-based colonoscopy study., Results: In LS, 30% of the individuals had adenomas and 10% advanced adenomas. The corresponding figures in the other risk groups were 14-24% and 4-7%, compared with 10% and 3% in the control group. The relative risk of having adenomas and advanced adenomas was, compared to controls, significantly higher for all risk groups except the group with the lowest risk. Age was a strong predictor for adenomas and advanced adenomas in both risk individuals and controls., Conclusions: Individuals with a family history of CRC have a high prevalence and cumulative risk of adenomas and advanced adenomas, and screening is motivated also in this risk group.
- Published
- 2015
- Full Text
- View/download PDF
4. Celiac disease, eosinophilic esophagitis and gastroesophageal reflux disease, an adult population-based study.
- Author
-
Ludvigsson JF, Aro P, Walker MM, Vieth M, Agréus L, Talley NJ, Murray JA, and Ronkainen J
- Subjects
- Adult, Aged, Aged, 80 and over, Barrett Esophagus complications, Barrett Esophagus diagnosis, Barrett Esophagus epidemiology, Biopsy, Case-Control Studies, Celiac Disease diagnosis, Celiac Disease epidemiology, Cohort Studies, Endoscopy, Gastrointestinal, Eosinophilic Esophagitis diagnosis, Eosinophilic Esophagitis epidemiology, Esophagitis, Peptic complications, Esophagitis, Peptic diagnosis, Esophagitis, Peptic epidemiology, Esophagus pathology, Female, Gastroesophageal Reflux diagnosis, Gastroesophageal Reflux epidemiology, Humans, Intestinal Mucosa pathology, Intestine, Small pathology, Male, Middle Aged, Prevalence, Single-Blind Method, Surveys and Questionnaires, Sweden epidemiology, Celiac Disease complications, Eosinophilic Esophagitis complications, Gastroesophageal Reflux complications
- Abstract
Objective: Celiac disease (CD) has been linked to gastroesophageal reflux disease (GORD) and eosinophilic esophagitis (EoE), but population-based studies of the prevalence of CD in these conditions are lacking, that is, the aim of this study., Materials and Methods: An endoscopic study was carried out in 1000 randomly selected adults from the general population. CD was defined on the basis of positive serology in parallel with mucosal abnormalities of the small intestine. Any eosinophil infiltration of the esophageal epithelium was defined as esophageal eosinophilia and EoE was defined as having at least 15 eosinophils/high-power field in biopsies from the distal esophagus. We used Fisher's exact test to compare the prevalence of GORD, esophageal eosinophilia, and EoE in subjects with CD versus controls., Results: Four hundred subjects (40%) had gastroesophageal reflux symptoms (GORS), 155 (15.5%) had erosive esophagitis, 16 (1.6%) had Barrett's esophagus, 48 (4.8%) had esophageal eosinophilia, and 11 (1.1%) had EoE. CD was diagnosed in 8/400 (2.0%) individuals with GORS (vs. controls: 10/600 (1.7%), p = 0.81), in 3/155 (1.9%) with erosive esophagitis (vs. 15/845 controls (1.8%), p = 0.75), and in 2/48 (4.2%) individuals with esophageal eosinophilia (controls: 16/952 (1.7%), p = 0.21), but in none of those 16 with Barrett's esophagus (vs. 18/984 controls (1.8%), p = 1.0) or of the 11 individuals with EoE (controls: 18/989 (1.8%), p = 1.0)., Conclusions: This population-based study found no increased risk of CD among individuals with GORD, esophageal eosinophilia, or EoE. CD screening of individuals with GORD or EoE of individuals with CD cannot be recommended.
- Published
- 2013
- Full Text
- View/download PDF
5. Rationale in diagnosis and screening of atrophic gastritis with stomach-specific plasma biomarkers.
- Author
-
Agréus L, Kuipers EJ, Kupcinskas L, Malfertheiner P, Di Mario F, Leja M, Mahachai V, Yaron N, van Oijen M, Perez Perez G, Rugge M, Ronkainen J, Salaspuro M, Sipponen P, Sugano K, and Sung J
- Subjects
- Achlorhydria blood, Achlorhydria complications, Antibodies, Bacterial blood, Gastric Mucosa microbiology, Gastric Mucosa pathology, Gastric Mucosa physiopathology, Gastrins blood, Gastritis, Atrophic microbiology, Helicobacter Infections microbiology, Helicobacter pylori immunology, Humans, Mass Screening, Pepsinogen A blood, Pepsinogen C blood, Stomach Neoplasms complications, Stomach Neoplasms diagnosis, Stomach Neoplasms prevention & control, Vitamin B 12 pharmacokinetics, Biomarkers blood, Gastritis, Atrophic blood, Gastritis, Atrophic diagnosis, Helicobacter Infections blood, Helicobacter Infections diagnosis
- Abstract
Background and Aims: Atrophic gastritis (AG) results most often from Helicobacter pylori (H. pylori) infection. AG is the most important single risk condition for gastric cancer that often leads to an acid-free or hypochlorhydric stomach. In the present paper, we suggest a rationale for noninvasive screening of AG with stomach-specific biomarkers., Methods: The paper summarizes a set of data on application of the biomarkers and describes how the test results could be interpreted in practice., Results: In AG of the gastric corpus and fundus, the plasma levels of pepsinogen I and/or the pepsinogen I/pepsinogen II ratio are always low. The fasting level of gastrin-17 is high in AG limited to the corpus and fundus, but low or non-elevated if the AG occurs in both antrum and corpus. A low fasting level of G-17 is a sign of antral AG or indicates high intragastric acidity. Differentiation between antral AG and high intragastric acidity can be done by assaying the plasma G-17 before and after protein stimulation, or before and after administration of the proton pump inhibitors (PPI). Amidated G-17 will rise if the antral mucosa is normal in structure. H. pylori antibodies are a reliable indicator of helicobacter infection, even in patients with AG and hypochlorhydria., Conclusions: Stomach-specific biomarkers provide information about the stomach health and about the function of stomach mucosa and are a noninvasive tool for diagnosis and screening of AG and acid-free stomach.
- Published
- 2012
- Full Text
- View/download PDF
6. Prevalence of colonic neoplasia and advanced lesions in the normal population: a prospective population-based colonoscopy study.
- Author
-
Forsberg AM, Kjellström L, Agréus L, Nixon Andreasson A, Nyhlin H, Talley NJ, and Björck E
- Subjects
- Adenoma pathology, Adult, Aged, Colonic Neoplasms pathology, Colonoscopy, Female, Humans, Male, Middle Aged, Prevalence, Prospective Studies, Sweden epidemiology, Young Adult, Adenoma epidemiology, Carcinoma epidemiology, Colonic Neoplasms epidemiology
- Abstract
Objective: There are few prospective studies of the prevalence of colonic neoplasia in the normal population. In order to properly evaluate screening-protocols for colorectal cancer in risk groups (e.g., older subjects or those with a family history), it is essential to know the prevalence of adenomas and cancer in the normal population., Methods: A prospective population-based colonoscopy study on 745 individuals born in Sweden aged 19-70 years was conducted (mean age 51.1 years). All polyps seen were retrieved and examined., Results: Out of the 745 individuals 27% had polyps, regardless of kind. Adenomas were found in 10% of the individuals and finding of adenomas was positively correlated to higher age. Men had adenomas in 15% and women in 6% of the cases. Women had a right-sided dominance of adenomas. Hyperplastic polyps were seen in 21% of the individuals. The presence of hyperplastic polyps was significantly positively correlated to the presence of adenomas. Advanced adenomas were seen in 2.8% of the study participants, but no cancers were detected., Conclusion: One in 10 healthy subjects had an adenoma but advanced adenomas were uncommon. Men and women have a different adenoma prevalence and localization. The results provide baseline European data for evaluating colonoscopy screening-protocols for colorectal cancer risk groups, and the findings may have implications for colon cancer screening in the normal, otherwise-healthy population.
- Published
- 2012
- Full Text
- View/download PDF
7. Assessment of normal bowel habits in the general adult population: the Popcol study.
- Author
-
Walter SA, Kjellström L, Nyhlin H, Talley NJ, and Agréus L
- Subjects
- Adolescent, Adult, Aged, Colonoscopy, Female, Humans, Male, Middle Aged, Prospective Studies, Reference Values, Statistics, Nonparametric, Sweden, Defecation physiology, Gastroenterology methods
- Abstract
Objective: Defining normal stool habit is important when evaluating diarrhoea or constipation, but common confounders such as irritable bowel syndrome (IBS) or the intake of medications with gastrointestinal side effects have not been considered in earlier population based studies defining what is normal. We hypothesized that the exclusion of subjects with common confounders would help to better understand what are "normal bowel habits". We aimed to prospectively study bowel habits in a carefully studied random sample of the general population., Material and Methods: Two hundred and sixty-eight randomly selected subjects between 18 and 70 years completed symptom diaries for one week and were clinically evaluated by a gastroenterologist. They also had a colonoscopy and laboratory investigations to exclude organic disease., Results: One hundred and twenty-four subjects had no organic gastrointestinal abnormality, IBS, or relevant medication; 98% of them had between three stools per day and three per week. Seventy-seven percent of all stools were normal, 12% hard, and 10% loose in consistency. Urgency was reported by 36%; straining by 47% and incomplete defecation by 46%. After the exclusion of subjects with organic abnormalities, women had significantly more symptoms than men in terms of abdominal pain, bloating, constipation, urgency, and feeling of incomplete evacuation but these gender differences disappeared after excluding subjects with IBS., Conclusions: This study confirms that normal stool frequency is between three per week and three per day. We could not demonstrate any gender or age differences in terms of stool frequency, defecatory symptoms or abdominal bloating. Some degree of urgency, straining, and incomplete evacuation should be considered normal.
- Published
- 2010
- Full Text
- View/download PDF
8. Consultation rates and characteristics of gastro-oesophageal reflux disease in primary care: a European observational study.
- Author
-
Gisbert JP, Cooper A, Karagiannis D, Hatlebakk J, Agréus L, Jablonowski H, and Tafalla M
- Subjects
- Adult, Aged, Data Collection, Europe epidemiology, Female, Gastroesophageal Reflux epidemiology, Humans, Male, Middle Aged, Recurrence, Retrospective Studies, Gastroesophageal Reflux therapy, Practice Patterns, Physicians' statistics & numerical data, Primary Health Care statistics & numerical data, Referral and Consultation statistics & numerical data
- Abstract
Objective: To report on the primary care consultation rates and clinical characteristics of patients with gastro-oesophageal reflux disease (GERD) as part of the RANGE (Retrospective ANalysis of GERD) observational study., Methods: RANGE was conducted at 134 primary care centres across six European countries. All subjects who consulted their primary care physician during a 4-month identification period were screened retrospectively. Those consulting for GERD-related reasons were identified, and a randomly selected cohort underwent clinical interview., Results: Out of 373,610 consultations in the six countries, 12,815 (3.4%) were for GERD-related reasons (inter-country range: 1.4-7.4%). From 2678 patients interviewed (24.7% of whom had been previously diagnosed with reflux oesophagitis), symptom recurrence following remission was the most common reason for primary care consultation (35.1%; range: 22.3-51.7%). Some 12.7% of patients (range: 9.1-21.4%) consulted due to persistence of previous symptoms, and 16.2% (range: 8.2-35.6%) had never consulted before regarding GERD-related symptoms., Conclusion: consultation rates for GERD-related reasons, and the clinical characteristics of consulting patients, vary widely across Europe. Symptom recurrence after an initial period of remission, and persistent symptoms, were important reasons for consultation, emphasizing the need for improved management of primary care patients with GERD across Europe.
- Published
- 2009
- Full Text
- View/download PDF
9. Clinical use of proton-pump inhibitors but not H2-blockers or antacid/alginates raises the serum levels of amidated gastrin-17, pepsinogen I and pepsinogen II in a random adult population.
- Author
-
Agréus L, Storskrubb T, Aro P, Ronkainen J, Talley NJ, and Sipponen P
- Subjects
- Adult, Aged, Aged, 80 and over, Biomarkers blood, Cohort Studies, Dose-Response Relationship, Drug, Drug Administration Schedule, Female, Follow-Up Studies, Gastric Acid metabolism, Gastric Mucosa pathology, Gastrins metabolism, Histamine H2 Antagonists adverse effects, Humans, Male, Middle Aged, Pepsinogen A blood, Pepsinogen C blood, Pepsinogens metabolism, Probability, Proton Pump Inhibitors therapeutic use, Risk Assessment, Statistics, Nonparametric, Surveys and Questionnaires, Young Adult, Gastric Mucosa drug effects, Gastrins blood, Histamine H2 Antagonists therapeutic use, Pepsinogens blood, Proton Pump Inhibitors adverse effects
- Abstract
Objective: Proton-pump inhibitors (PPIs), H(2) receptor antagonists (H(2)RAs) and antacids/alginates reduce intragastric acidity and may thus influence normal gastric physiology. The purpose of this study was to examine the effect of these compounds on serum levels of amidated gastrin-17 (G-17) and pepsinogens (PGI & PGII) in a large, random, adult Swedish population sample with uninfected stomach mucosa., Material and Methods: The initial sample subjects (n=1000, mean age 50 years, range 20-80 years) completed a questionnaire on the use of acid inhibitory drugs 1 week and/or 3 months before study entry. All subjects (n=590) with normal gastric mucosa as delineated by serum biomarkers were included. Among them, serum levels of PGI, PGII and G-17 were compared between those who used acid inhibitory drugs and those who did not., Results: The serum levels of G-17 or pepsinogens in the subjects who reported use of H(2)RAs (n=18) or antacid/alginates (n=66) during the previous 3 months did not differ from those in non-users (n=471). However, the median levels of G-17 and pepsinogens were significantly (p<0.001) higher among the PPI users (n=35) than among non-users: the levels were approximately doubled. The ratio of PGI/PGII was, however, similar between PPI users and non-users, or those using antacids/alginates or H(2)RAs. Among subjects using PPIs, the serum levels of pepsinogens correlated positively (p<0.01) with the serum levels of G-17., Conclusions: PPIs but not antacids/alginates or H(2)RAs markedly increase the fasting levels of serum amidated G-17 and pepsinogens among ordinary patients in everyday clinical practice.
- Published
- 2009
- Full Text
- View/download PDF
10. Serum biomarkers provide an accurate method for diagnosis of atrophic gastritis in a general population: The Kalixanda study.
- Author
-
Storskrubb T, Aro P, Ronkainen J, Sipponen P, Nyhlin H, Talley NJ, Engstrand L, Stolte M, Vieth M, Walker M, and Agréus L
- Subjects
- Biomarkers blood, Female, Gastrins blood, Gastritis, Atrophic pathology, Helicobacter pylori immunology, Humans, Male, Middle Aged, Reproducibility of Results, Sensitivity and Specificity, Antibodies, Bacterial blood, Gastritis, Atrophic blood, Gastritis, Atrophic diagnosis, Pepsinogen A blood, Pepsinogen C blood
- Abstract
Objective: Serological biomarkers can be used for non-invasive diagnosis of gastritis and atrophic gastritis. The aim of this study was to compare the validity of serum levels of pepsinogen I (PGI) and II (PGII), gastrin-17 (G-17) and Helicobacter pylori antibodies (Hpab) with that of the gold standard histology for diagnosis of atrophic gastritis in a population sample from Northern Sweden., Material and Methods: In all, 1000 subjects underwent endoscopies with biopsies. Serum biomarkers were available in 976 subjects for independent diagnosis of gastric mucosal status using a predetermined diagnostic algorithm., Results: Overall agreement between histology and serological biomarkers in diagnosing corpus atrophy was 96% (CI 95%: 95-97%). Sensitivity and specificity of markers for atrophic gastritis were 71% (CI 68-74%) and 98% (CI 97-99%) respectively, corresponding to 69% (CI 95%: 66-72%) and 98% (95% CI 97-99%) positive and negative predictive values. The positive likelihood ratio was 35.5 (95% CI: 35.0-36.0%). In subgroups with normal stomachs, H. pylori non-atrophic gastritis and H. pylori-negative gastritis by histology, the prevalence of corpus atrophy diagnosed with the biomarkers was 0.8% and 4.9%, respectively. In total, 6.6% of subjects in the study population had corpus atrophy according to the serological biomarkers. CONCLUSIONS. Serological biomarkers show a high degree of accuracy as a non-invasive method to diagnose corpus atrophy, which is common in the general population.
- Published
- 2008
- Full Text
- View/download PDF
11. High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: a Kalixanda study report.
- Author
-
Ronkainen J, Aro P, Storskrubb T, Johansson SE, Lind T, Bolling-Sternevald E, Graffner H, Vieth M, Stolte M, Engstrand L, Talley NJ, and Agréus L
- Subjects
- Adult, Antibodies, Bacterial blood, Biopsy, Endoscopy, Digestive System, Esophagitis etiology, Esophagitis pathology, Female, Gastroesophageal Reflux etiology, Gastroesophageal Reflux pathology, Helicobacter Infections complications, Helicobacter Infections microbiology, Helicobacter pylori immunology, Hernia, Hiatal complications, Humans, Immunoenzyme Techniques, Male, Middle Aged, Obesity complications, Prevalence, Retrospective Studies, Risk Factors, Surveys and Questionnaires, Sweden epidemiology, Esophagitis epidemiology, Gastroesophageal Reflux epidemiology, Population Surveillance methods
- Abstract
Objective: Gastroesophageal reflux disease has been reported to be a common burden on health-care resources in the Western world, but its manifestations in the general population are as yet unclear. The aim of this study was to estimate the prevalence of, and to identify the risk factors for gastroesophageal reflux symptoms (GERS) and erosive esophagitis (EE) in the adult population of two Swedish municipalities., Material and Methods: A random sample (n =3000) of the adult population (20-81 years of age) of two Swedish municipalities (n =21,610) was surveyed using a validated postal questionnaire assessing gastrointestinal symptoms. The response rate was 74%. A subsample (n = 1000) of the responders was subsequently invited, in random order, for esophago-gastro-duodenoscopy with evaluation of GERS, risk factors and tests for Helicobacter pylori., Results: GERS were reported by 40.0% and EE was found in 15.5% of the population that had undergone endoscopy. Of those with GERS, 24.5% had EE while 36.8% of those with EE reported no GERS. Hiatus hernia and obesity remained significant risk factors for GERS and/or EE, with or without symptoms in a main effect model (OR up to 14 at EE). Those with active H. pylori infection had a higher risk of GERS without EE than those without H. pylori infection (OR = 1.71 (1.23 2.38))., Conclusions: GERS and EE (of which one-third is asymptomatic) are highly prevalent in the Swedish adult population. H. pylori infection seems to play a role in the manifestations of gastroesophageal reflux.
- Published
- 2005
- Full Text
- View/download PDF
12. A negative Helicobacter pylori serology test is more reliable for exclusion of premalignant gastric conditions than a negative test for current H. pylori infection: a report on histology and H. pylori detection in the general adult population.
- Author
-
Storskrubb T, Aro P, Ronkainen J, Vieth M, Stolte M, Wreiber K, Engstrand L, Nyhlin H, Bolling-Sternevald E, Talley NJ, and Agréus L
- Subjects
- Adult, Aged, Aged, 80 and over, Biopsy, Diagnosis, Differential, Endoscopy, Digestive System, Enzyme-Linked Immunosorbent Assay, Female, Gastritis, Atrophic pathology, Helicobacter Infections pathology, Humans, Male, Middle Aged, Population Surveillance, Precancerous Conditions pathology, Pyloric Antrum pathology, Random Allocation, Reproducibility of Results, Retrospective Studies, Serologic Tests, Surveys and Questionnaires, Sweden, Antibodies, Bacterial blood, Gastric Mucosa pathology, Gastritis, Atrophic microbiology, Helicobacter Infections microbiology, Helicobacter pylori immunology, Precancerous Conditions microbiology, Stomach Neoplasms pathology
- Abstract
Objective: Corpus-dominant gastritis, gastric mucosal atrophy and intestinal metaplasia (IM) associated with Helicobacter pylori infection are all known potential risk markers for the development of gastric cancer. As the accuracy for finding cases at risk in the general population is unknown, we aimed to determine the prevalence of current and/or past H. pylori infection and associated gastric mucosal findings by means of histological survey of a random adult population., Material and Methods: A random Swedish sample (n = 3000, age 20-81 years) was surveyed using a validated gastrointestinal symptom questionnaire with 74% response rate. One-third of the responders were selected at random for esophago-gastro-duodenoscopy with biopsies and H. pylori serology., Results: Of those endoscoped (n = 1000, mean age 53.5, 51% women), 43.0% were H. pylori+ by serology (seropositive), 33.9% had signs of current infection on either histology or culture (gold standard+), and 9.3% were seropositive, but gold standard negative. Corpus atrophy was found in 10% and IM in 13% when gold standard positive, and in a significantly higher number (17% and 21%, respectively) of those with only a serological sign of past infection. Among those who were seronegative, values were 1% and 2%, respectively. Corpus-dominant gastritis was found in 4.1%, all seropositive., Conclusion: One-third had an ongoing H. pylori infection, and a further 10% had signs of past infection. Corpus-dominant gastritis was found mostly among the former, while detection of those with corpus atrophy and IM also required a test for past infection. Seronegativity almost excludes precancerous conditions in a screening situation.
- Published
- 2005
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.